Chwiecko J - Search Results

1

Effect of repeated infliximab therapy on serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with rheumatoid arthritis.

Klimiuk PA, Sierakowski S, Domyslawska I, Chwiecko J. Klimiuk PA, et al. Among authors: chwiecko j. J Rheumatol. 2004 Feb;31(2):238-42. J Rheumatol. 2004. PMID: 14760791 Clinical Trial.

2

[Correlation between tumor necrosis factor alpha and matrix metalloproteinases levels in serum of patients with rheumatic arthritis].

Klimiuk PA, Sierakowski S, Chwiećko J. Klimiuk PA, et al. Among authors: chwiecko j. Pol Merkur Lekarski. 2003 May;14(83):410-2. Pol Merkur Lekarski. 2003. PMID: 12939814 Polish.

3

Reduction of soluble adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor levels in serum of rheumatoid arthritis patients following multiple intravenous infusions of infliximab.

Klimiuk PA, Sierakowski S, Domysławska I, Fiedorczyk M, Chwiećko J. Klimiuk PA, et al. Among authors: chwiecko j. Arch Immunol Ther Exp (Warsz). 2004 Jan-Feb;52(1):36-42. Arch Immunol Ther Exp (Warsz). 2004. PMID: 15053231

4

[Serum tumor necrosis factor alpha (TNF-alpha) concentration correlates with soluble adhesion molecules and vascular endothelial growth factor (VEGF) in rheumatoid arthritis].

Klimiuk PA, Sierakowski S, Fiedorczyk M, Chwiećko J. Klimiuk PA, et al. Among authors: chwiecko j. Przegl Lek. 2004;61(2):86-9. Przegl Lek. 2004. PMID: 15230147 Polish.

5

Histological patterns of synovitis and serum chemokines in patients with rheumatoid arthritis.

Klimiuk PA, Sierakowski S, Latosiewicz R, Skowronski J, Cylwik JP, Cylwik B, Chwiecko J. Klimiuk PA, et al. Among authors: chwiecko j. J Rheumatol. 2005 Sep;32(9):1666-72. J Rheumatol. 2005. PMID: 16142858

6

Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis.

Fiedorczyk M, Klimiuk PA, Sierakowski S, Gindzienska-Sieskiewicz E, Chwiecko J. Fiedorczyk M, et al. Among authors: chwiecko j. J Rheumatol. 2006 Aug;33(8):1523-9. J Rheumatol. 2006. PMID: 16881109

7

The changes in serum chemokines following leflunomide therapy in patients with rheumatoid arthritis.

Klimiuk PA, Kita J, Chwiecko J, Sierakowski S. Klimiuk PA, et al. Among authors: chwiecko j. Clin Rheumatol. 2009 Jan;28(1):17-21. doi: 10.1007/s10067-008-0974-1. Epub 2008 Jul 29. Clin Rheumatol. 2009. PMID: 18663553 Clinical Trial.

8

Serum chemokines in patients with rheumatoid arthritis treated with etanercept.

Klimiuk PA, Sierakowski S, Domyslawska I, Chwiecko J. Klimiuk PA, et al. Among authors: chwiecko j. Rheumatol Int. 2011 Apr;31(4):457-61. doi: 10.1007/s00296-009-1299-3. Epub 2009 Dec 19. Rheumatol Int. 2011. PMID: 20024555

9

Regulation of serum matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 following rituximab therapy in patients with rheumatoid arthritis refractory to anti-tumor necrosis factor blockers.

Klimiuk PA, Domysławska I, Sierakowski S, Chwiećko J. Klimiuk PA, et al. Among authors: chwiecko j. Rheumatol Int. 2015 Apr;35(4):749-55. doi: 10.1007/s00296-014-3112-1. Epub 2014 Sep 5. Rheumatol Int. 2015. PMID: 25190551 Free PMC article.

10

[Serum interleukin 6 (il-6A) concentration correlates with matrix metalloproteinases and their tissue inhibitors in rheumatoid arthritis].

Klimiuk PA, Sierakowski S, Chwiećko J. Klimiuk PA, et al. Among authors: chwiecko j. Pol Arch Med Wewn. 2003 Feb;109(2):119-23. Pol Arch Med Wewn. 2003. PMID: 12879774 Polish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters